Kevin A Sevarino

Title: Kevin A Sevarino: Innovator in Excitatory Glycine Receptors

Introduction

Kevin A Sevarino is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of neuroscience through his innovative work on excitatory glycine receptors. With a total of 2 patents, his inventions have the potential to impact diagnostic and therapeutic methods in medical science.

Latest Patents

Sevarino's latest patents focus on excitatory glycine receptors and methods. The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Additionally, the patents include excitatory glycine receptors that contain either NR3B or NR3A polypeptides. The methods outlined in the patents are designed for detecting excitatory glycine receptor ligands, agonists, and antagonists. Furthermore, the invention offers related diagnostic and therapeutic methods.

Career Highlights

Throughout his career, Sevarino has worked with esteemed institutions such as the Sanford-Burnham Medical Research Institute and Yale University. His experience in these organizations has contributed to his expertise in the field of neuroscience and receptor biology.

Collaborations

Some of his notable coworkers include Stuart A Lipton and Dongxian Zhang. Their collaborative efforts have likely enhanced the research and development of innovative solutions in their respective fields.

Conclusion

Kevin A Sevarino's work on excitatory glycine receptors showcases his dedication to advancing medical science through innovation. His patents reflect a commitment to developing methods that could lead to significant breakthroughs in diagnostics and therapeutics.